Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Gasser

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Topics in Behavioral Neurosciences|January 29, 2022
Psychedelic Group TherapyPeter Gasser
Frontiers in Psychiatry|May 13, 2022
Using a MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related DisordersPeter Oehen, Peter Gasser
Current Topics in Behavioral Neurosciences|August 27, 2024
Guiding Through Challenging Psychedelic Experiences and "Bad Trips"Michael Koslowski, Peter Gasser
Journal of Psychopharmacology (Oxford, England)|November 13, 2014
LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effectsPeter Gasser, Katharina Kirchner, Torsten Passie
Frontiers in Psychiatry|February 18, 2025
Treatment of neuropathic pain with repeated low-dose MDMA: a case reportPeter Gasser, Matthias E Liechti, Friederike Holze
Journal of Psychopharmacology (Oxford, England)|April 15, 2021
Acute subjective effects in LSD- and MDMA-assisted psychotherapyYasmin Schmid, Peter Gasser, Peter Oehen, et al.
BMC Medical Ethics|December 8, 2017
Attitudes towards assisted suicide and euthanasia among care-dependent older adults (50+) in Austria: the role of socio-demographics, religiosity, physical illness, psychological distress, and social isolationErwin Stolz, Hannes Mayerl, Peter Gasser-Steiner, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 30, 2024
LSD-assisted therapy in patients with anxiety: open-label prospective 12-month follow-upFriederike Holze, Peter Gasser, Felix Müller, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 27, 2017
Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic reviewSimon Reiche, Leo Hermle, Stefan Gutwinski, et al.
Biological Psychiatry|October 20, 2022
Lysergic Acid Diethylamide-Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II StudyFriederike Holze, Peter Gasser, Felix Müller, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Topics in Behavioral Neurosciences|January 29, 2022
Psychedelic Group TherapyPeter Gasser
Frontiers in Psychiatry|May 13, 2022
Using a MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related DisordersPeter Oehen, Peter Gasser
Current Topics in Behavioral Neurosciences|August 27, 2024
Guiding Through Challenging Psychedelic Experiences and "Bad Trips"Michael Koslowski, Peter Gasser
Journal of Psychopharmacology (Oxford, England)|November 13, 2014
LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effectsPeter Gasser, Katharina Kirchner, Torsten Passie
Frontiers in Psychiatry|February 18, 2025
Treatment of neuropathic pain with repeated low-dose MDMA: a case reportPeter Gasser, Matthias E Liechti, Friederike Holze
Journal of Psychopharmacology (Oxford, England)|April 15, 2021
Acute subjective effects in LSD- and MDMA-assisted psychotherapyYasmin Schmid, Peter Gasser, Peter Oehen, et al.
BMC Medical Ethics|December 8, 2017
Attitudes towards assisted suicide and euthanasia among care-dependent older adults (50+) in Austria: the role of socio-demographics, religiosity, physical illness, psychological distress, and social isolationErwin Stolz, Hannes Mayerl, Peter Gasser-Steiner, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 30, 2024
LSD-assisted therapy in patients with anxiety: open-label prospective 12-month follow-upFriederike Holze, Peter Gasser, Felix Müller, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 27, 2017
Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic reviewSimon Reiche, Leo Hermle, Stefan Gutwinski, et al.
Biological Psychiatry|October 20, 2022
Lysergic Acid Diethylamide-Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II StudyFriederike Holze, Peter Gasser, Felix Müller, et al.
Pageof 2